After three years of stealthy research and development, Halifax’s Sparrow Biologic has raised $3.25 million in a pre-Series A funding round led by family offices Killick Capital and Klister Credit Corp., as it prepares to seek regulatory approval from Health Canada and the Food and Drug Administration.
Sparrow is developing technology that will use smartphone mics to assess users’ health based on their bodily sounds, such as breathing. The company was founded in 2018 by a group of five entrepreneurs: Nadia Ivanova, David Rankin, Yaroslav Shpak, Max Davydov and Yuri Heiko. Killick Capital